Shaping New Markets, One Rare Condition at a Time

Session details:

In rare disease, marketers aren’t just promoting treatments—they’re creating entirely new markets, redefining education, and rewriting the playbook for engagement. This session explores how pharma leaders are shaping awareness before launch, building trust across small but passionate communities, and driving access in conditions that have long gone untreated. Hear how collaboration between marketing, medical, and patient advocacy can transform awareness into action in even the rarest spaces. 

• Discuss how to educate and activate stakeholders pre-launch when awareness and diagnosis are still limited.
• Learn how leading rare-disease marketers partner across functions to balance scientific storytelling with empathy and credibility.
• Hear how successful brands sustain engagement post-launch to build long-term trust, advocacy, and access for patients who’ve waited decades for solutions.